Triveni Bio
Brantley Herrin is a highly experienced professional with expertise in biologics discovery, molecular and cell biology, protein engineering, and platform technologies. They have worked in various roles at companies such as Triveni Bio, Acceleron Pharma, Energesis Pharmaceuticals, Unum Therapeutics, and NovAb, Inc. Brantley also has a background as an Assistant Professor at Emory University School of Medicine and as a Graduate Student at the University of Alabama at Birmingham. Their Ph.D. in Microbiology solidifies their knowledge and skills in the field.
This person is not in any teams
Triveni Bio
Triveni Bio is a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. The company’s approach establishes proof-of-concept at the earliest stages of drug development. Through a strong understanding of genetics and mechanistic biology, our pipeline is powered for indication expansion where we know we can have the most impact. To learn more, visit www.triveni.bio.